These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 25415323)
1. Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection. Boyd A; Meynard JL; Morand-Joubert L; Michon A; Boccara F; Bastard JP; Samri A; Haddour N; Mallat Z; Capeau J; Desvarieux M; Girard PM; PLoS One; 2014; 9(11):e113876. PubMed ID: 25415323 [TBL] [Abstract][Full Text] [Related]
2. HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative. Hanna DB; Guo M; Bůžková P; Miller TL; Post WS; Stein JH; Currier JS; Kronmal RA; Freiberg MS; Bennett SN; Shikuma CM; Anastos K; Li Y; Tracy RP; Hodis HN; Delaney JA; Kaplan RC Clin Infect Dis; 2016 Jul; 63(2):249-56. PubMed ID: 27118787 [TBL] [Abstract][Full Text] [Related]
3. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. McComsey GA; O'Riordan M; Hazen SL; El-Bejjani D; Bhatt S; Brennan ML; Storer N; Adell J; Nakamoto DA; Dogra V AIDS; 2007 May; 21(8):921-7. PubMed ID: 17457085 [TBL] [Abstract][Full Text] [Related]
4. Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients. Mercié P; Thiébaut R; Aurillac-Lavignolle V; Pellegrin JL; Yvorra-Vives MC; Cipriano C; Neau D; Morlat P; Ragnaud JM; Dupon M; Bonnet F; Lawson-Ayayi S; Malvy D; Roudaut R; Dabis F; HIV Med; 2005 Nov; 6(6):380-7. PubMed ID: 16268819 [TBL] [Abstract][Full Text] [Related]
5. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score. Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026 [TBL] [Abstract][Full Text] [Related]
6. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Lorenz MW; Stephan C; Harmjanz A; Staszewski S; Buehler A; Bickel M; von Kegler S; Ruhkamp D; Steinmetz H; Sitzer M Atherosclerosis; 2008 Feb; 196(2):720-6. PubMed ID: 17275008 [TBL] [Abstract][Full Text] [Related]
7. Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome. Johnsen S; Dolan SE; Fitch KV; Kanter JR; Hemphill LC; Connelly JM; Lees RS; Lee H; Grinspoon S J Clin Endocrinol Metab; 2006 Dec; 91(12):4916-24. PubMed ID: 17003092 [TBL] [Abstract][Full Text] [Related]
8. Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy. Desvarieux M; Boccara F; Meynard JL; Bastard JP; Mallat Z; Charbit B; Demmer RT; Haddour N; Fellahi S; Tedgui A; Cohen A; Capeau J; Boyd A; Girard PM AIDS; 2013 Oct; 27(16):2603-14. PubMed ID: 24100713 [TBL] [Abstract][Full Text] [Related]
9. Long-term changes in carotid intima-media thickness among HIV-infected children and young adults. Ross Eckard A; O'Riordan MA; Storer N; McComsey GA Antivir Ther; 2014; 19(1):61-8. PubMed ID: 23985545 [TBL] [Abstract][Full Text] [Related]
10. Increased carotid intima-media thickness is not associated with T-cell activation nor with cytomegalovirus in HIV-infected never-smoker patients. Goulenok T; Boyd A; Larsen M; Fastenackels S; Boccara F; Meynard JL; Hadour N; Samri A; Desvarieux M; Autran B; Appay V; Girard PM; Sauce D; AIDS; 2015 Jan; 29(3):287-93. PubMed ID: 25686677 [TBL] [Abstract][Full Text] [Related]
11. The intake of flavonoids and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. Mursu J; Nurmi T; Tuomainen TP; Ruusunen A; Salonen JT; Voutilainen S Br J Nutr; 2007 Oct; 98(4):814-8. PubMed ID: 17466095 [TBL] [Abstract][Full Text] [Related]
12. Association of Viral Persistence and Atherosclerosis in Adults With Treated HIV Infection. McLaughlin MM; Ma Y; Scherzer R; Rahalkar S; Martin JN; Mills C; Milush J; Deeks SG; Hsue PY JAMA Netw Open; 2020 Oct; 3(10):e2018099. PubMed ID: 33119103 [TBL] [Abstract][Full Text] [Related]
13. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml. Mohey R; Jørgensen LB; Møller BK; Black FT; Kjems J; Obel N J Clin Virol; 2005 Dec; 34(4):257-67. PubMed ID: 16286049 [TBL] [Abstract][Full Text] [Related]
14. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients. Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412 [TBL] [Abstract][Full Text] [Related]
15. Progression of carotid intima-media thickness and coronary artery calcium over 6 years in an HIV-infected cohort. Volpe GE; Tang AM; Polak JF; Mangili A; Skinner SC; Wanke CA J Acquir Immune Defic Syndr; 2013 Sep; 64(1):51-7. PubMed ID: 23945252 [TBL] [Abstract][Full Text] [Related]